Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,233,742
+$44,138 QoQ
Shares Held
3,407
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,553
of 3,140 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Financial Advisors, Inc. holds $18,531,940 across 8 Drug Manufacturers - General names. AMGN ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,438 | $4,123,640 | |
| 2 | JNJ |
Johnson & Johnson
|
15,452 | $3,924,344 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,939 | $3,718,661 | |
| 4 | ABBV |
AbbVie Inc.
|
9,983 | $2,512,122 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,235 | $1,511,660 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,407 | $1,233,742 | |
| 7 | PFE |
Pfizer Inc
|
34,409 | $828,568 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,376 | $679,203 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,233,742 | 3,407 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,189,604 | 3,381 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,015,970 | 3,104 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $919,407 | 3,258 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $927,256 | 3,321 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,054,049 | 6,593 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,719,181 | 6,596 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,819,842 | 5,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,751,907 | 5,607 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,593,044 | 5,603 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,583,533 | 5,498 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,424,159 | 5,299 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,057,703 | 4,764 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,142,268 | 4,725 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,167,434 | 4,445 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $897,768 | 3,983 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $957,872 | 3,937 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $862,813 | 3,568 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $768,722 | 3,417 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $630,932 | 2,967 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $743,193 | 3,049 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $765,588 | 3,077 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $613,886 | 2,670 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $647,599 | 2,548 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||